key: cord-0825996-947mqm6t authors: Gottesman, Bat-Sheva; Low, Marcelo; Netzer, Doron; Almog, Ronit; Chowers, Michal title: Community antibiotic prescriptions during COVID-19 era: A population-based cohort study among adults date: 2022-03-10 journal: Clin Microbiol Infect DOI: 10.1016/j.cmi.2022.02.035 sha: 5f5cffd47879b55f2b7d86c593dce082b98325f6 doc_id: 825996 cord_uid: 947mqm6t OBJECTIVE: This study investigated the association between the COVID-19 pandemic and antibiotic prescription ratios and its determinants in the community. METHODS: The study was based on a retrospective population cohort of adults in a community setting. Antibiotic prescription ratios from March 1, 2020, to February 28, 2021 (COVID-19 period) were compared to similar months in previous years. Differences in visit type, infectious disease-related visit and antibiotic prescription ratios during these visits were compared. A logistic regression model was used to identify independent determinants of antibiotic prescription during the study period. RESULTS: The cohort included almost 3 million individuals with over 33 million community medical encounters per year. In the COVID-19 period, antibiotic prescription ratio decreased 45% (from 34.2 prescriptions/100 patients to 19.1/100) compared to the previous year. Visits due to an infectious disease (ID) etiology decreased by 10% and prescriptions per visit decreased by 39% (from 1,034,425 prescriptions/3,764,235 ID visits, to 587,379/3,426,451 respectively). This decrease was observed in both sexes and all age groups. Telemedicine visits were characterized by 10% lower prescription ratio compared to in-person visits. Thus, a threefold increase in telemedicine visits resulted in a further decrease in prescription ratios. The COVID-19 period was independently associated with a decrease in antibiotic prescription, with an odds ratio of 0.852 (95%CI 0.848, 0.857). CONCLUSION: We describe a significant decrease in antibiotic prescription ratios during the COVID-19 periods that was likely related to a decrease in the incidence of certain infectious diseases, in the transfer to telemedicine, and to a change in prescription practices among community-based physicians. Community antibiotic prescriptions during COVID-19 era: A population-based cohort study among adults March 1, 2018 , to February 28, 2021 10.6% 37.6% 45% Objective: This study investigated the association between the COVID-19 pandemic and 25 antibiotic prescription ratios and its determinants in the community. Methods: The study was based on a retrospective population cohort of adults in a community 27 setting. Antibiotic prescription ratios from March 1, 2020 , to February 28, 2021 period) were compared to similar months in previous years. Differences in visit type, infectious 29 disease-related visit and antibiotic prescription ratios during these visits were compared. A 30 logistic regression model was used to identify independent determinants of antibiotic 31 prescription during the study period. to the effect of SARS-Co V-2 on seasonal viral infections such as influenza and RSV. The COVID-19 pandemic completely changed social norms and behaviours, with the addition of 53 lockdowns and other social distancing methods, enhanced hand washing and mask wearing. Universal masking, as well as social distancing were implemented in Israel, throughout the entire 55 year (March 2020-February 2021). These dramatic changes were expected to decrease other 56 transmissible infectious diseases and antibiotic use. Moreover, many visits that were previously 57 conducted in-person were transferred to telemedicine encounters due to infection control 58 policies. The effect of this change in patient-physician interactions on antibiotic prescription was 59 unknown. Reports from hospitals around the world described increased antibiotic use, which was driven 61 mainly by severe COVID-19 cases [1, 2] . This effect could not be extrapolated to the community 62 because patient characteristics and antibiotic use differ. Initial reports from the community 63 described decreased prescription of antibiotics, but those encompassed only the first few months 64 of the pandemic; thereby, missing a possible effect of seasonal variations [3] [4] [5] . The CHS Research Ethics Committee approved this retrospective study and waived the 92 requirement for informed consent. The antibiotic prescription event ratio per 100 registered patients was calculated for each year. Since there was some variability in the number of registered patients over the months, the The overall change in antibiotic prescription ratios before and after the pandemic began in Israel 106 (March 2020), controlling for seasonality and age was assessed using an interrupted time series proportional to the mean, was fit, with the prescription count as the dependent variable and the 112 natural log of the insured population count as offset. The independent variables included the time since the start of the study, an indicator for the COVID-19 period, and the age group. In addition, 114 a harmonic term, representing a sine-cosine trend across the two periods, was added to adjust for 115 seasonality. In order to assess the association between periods (COVID-19 vs. pre-COVID 2018-2019) and Data were analysed using SPSS, version 23 (IBM Corp., Armonk, NY). Results were considered 126 significant when the p-value was less than 0.05 in a two-sided test. A 45.4 and 45.9% decrease in the antibiotic prescription ratio was observed in 2020 compared to 135 2018, 2019 respectively. (Table 1 ). This marked decrease was observed in both sexes, across 136 age groups and in the different population sectors. The decrease in antibiotic prescription over 137 time according to age group is shown in Figure 1 . The monthly ratios show that the major 138 decrease in antibiotic prescription occurred in April 2020, one month after the first COVID-19 139 cases appeared in Israel. The usual seasonal winter peaks did not appear in 2020. SARS-CoV-2 among those ID etiologies was extremely low (about 0.5% or less), which 237 excludes the likelihood of these misdiagnoses (supp Table 2 ). The study included only 238 community antibiotic prescriptions that were given during an ID-related visit. Therefore, 239 antibiotics given in hospitals and other medical facilities were not included. However, the 240 community is the major impetus behind antibiotic use as a whole [22] . A possible concern is that 241 difficulty accessing care during the COVID-19 era might contribute to the observed decrease in J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f Antimicrobial stewardship in a pandemic: picking up the pieces Empiric antibacterial therapy and community-onset 270 bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a 271 multi-hospital cohort study Impact of the Coronavirus 273 Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States Effect of the coronavirus disease 2019 pandemic on antibiotic use in 277 primary care Impact of the COVID-19 Pandemic on Antibiotic Prescribing for 280 Common Infections in The Netherlands: A Primary Care-Based Observational Cohort Study Digital health nation: Israel's global big data innovation hub Antibacterial prescribing in primary care A national evaluation 331 of antibiotic expenditures by healthcare setting in the United States 8%) Infection diagnosed Upper respiratory tract 1 Lower respiratory tract 08%) 661,297 (1.91%) Fever Antibiotic prescription at visits with an infectious disease diagnosis, by diagnosis, visit type, demographic characteristics, and period 026 7%) 96,732/516,027 (18.7%) 168,203/1